Dr. Volker Seidl will be triumphant Dr. Uwe Ranft efficient January 1, 2024
Novus Global nowadays proclaims the impending retirement of Dr. Uwe Ranft from his function as managing director of Europe, the Center East and Africa (EMEA) and international strategic accounts. Dr. Volker Seidl will be triumphant him, bringing twenty years of in depth enjoy to the function.
“NOVUS has been lucky to have Uwe with us for the previous twenty years, with 14 of the ones on the helm of the industrial industry in EMEA,” says Senior Vice President & Leader Industrial Officer Ed Galo. “Underneath his management, NOVUS has reinforced its relationships with key accounts and grown its place as a pacesetter in clever diet answers all the way through Europe, the Center East, and Africa. We will be able to’t thank him sufficient for his years of provider and determination to his consumers and associates.”
Dr. Seidl joined NOVUS because the director of worldwide strategic accounts in 2021. On the time, his in depth enjoy within the chemical and animal diet industries integrated head of gross sales excellence and head of worldwide key account control at BASF Animal Diet.
In his new function, Dr. Seidl will lend a hand information NOVUS’ industrial technique inside of EMEA. Along with his duty for the worldwide strategic accounts industry, he’ll organize the EMEA gross sales and technical groups, leverage assets, and align company purposes to toughen industry expansion and ship price to consumers.
All the way through his tenure with NOVUS, Dr. Seidl has confirmed himself in a position for this new skilled alternative, Galo says.
“Volker has effectively led efforts to enhance partnerships and develop industry with international strategic accounts,” he says. “He’s added price to the buyer through growing and executing a unified framework to spot and organize strategic accounts in any respect ranges of our group. He’s the perfect chief to proceed this transformative paintings as the pinnacle of the industrial industry in EMEA and with our international strategic accounts.”
The transition duration will start right away and proceed thru January 1, 2024, when Dr. Seidl’s appointment takes impact. On January 1, Dr. Ranft will transfer to a senior advisory function and proceed to toughen the transition and the industry thru his retirement date, March 31, 2024.
Novus Global is the clever diet corporate combining international medical analysis with native insights to broaden cutting edge, complex generation that is helping protein manufacturers all over the world succeed in higher effects. Be informed extra at novusint.com.
Dr. Seidl
Dr. Uwe Ranft
